Chronic low-grade inflammation in insulin-sensitive tissues, such as the liver and visceral adipose tissue, is central to obesity-associated insulin resistance, glucose intolerance, and NAFLD progression [59,82]. The gene discussed is INS; the disease is Glucose intolerance.